991 related articles for article (PubMed ID: 28322168)
21. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.
Turner S; Nunn AJ; Fielding K; Choonara I
Acta Paediatr; 1999 Sep; 88(9):965-8. PubMed ID: 10519338
[TBL] [Abstract][Full Text] [Related]
22. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
[TBL] [Abstract][Full Text] [Related]
23. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit.
Gidey MT; Gebretsadkan YG; Tsadik AG; Welie AG; Assefa BT
Ital J Pediatr; 2020 Apr; 46(1):41. PubMed ID: 32245504
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for unlicensed and off-label drug use in children outside the hospital.
Schirm E; Tobi H; de Jong-van den Berg LT
Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
[TBL] [Abstract][Full Text] [Related]
25. Unlicensed and off-label prescription of drugs to children in primary health care: A systematic review.
Andrade SRA; Santos PANM; Andrade PHS; da Silva WB
J Evid Based Med; 2020 Nov; 13(4):292-300. PubMed ID: 33047516
[TBL] [Abstract][Full Text] [Related]
26. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU).
Jobanputra N; Save SU; Bavdekar SB
Int J Risk Saf Med; 2015; 27(3):113-21. PubMed ID: 26410245
[TBL] [Abstract][Full Text] [Related]
27. Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions : Comparative regulation framework of off label prescriptions in pediatrics: a review.
Guidi B; Parziale A; Nocco L; Maiese A; La Russa R; Di Paolo M; Turillazzi E
Int J Clin Pharm; 2022 Feb; 44(1):264-269. PubMed ID: 34495453
[TBL] [Abstract][Full Text] [Related]
28. Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study.
Oguz SS; Kanmaz HG; Dilmen U
Int J Clin Pharm; 2012 Feb; 34(1):136-41. PubMed ID: 22234653
[TBL] [Abstract][Full Text] [Related]
29. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.
van Riet-Nales DA; Schobben AF; Egberts TC; Rademaker CM
Clin Ther; 2010 May; 32(5):924-38. PubMed ID: 20685501
[TBL] [Abstract][Full Text] [Related]
30. Off-label prescribing in pediatric outpatients.
Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
[TBL] [Abstract][Full Text] [Related]
31. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
[TBL] [Abstract][Full Text] [Related]
32. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.
Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B
Therapie; 2021; 76(6):675-685. PubMed ID: 33593598
[TBL] [Abstract][Full Text] [Related]
33. Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review.
Shuib W; Wu XY; Xiao F
World J Pediatr; 2021 Aug; 17(4):341-354. PubMed ID: 34080130
[TBL] [Abstract][Full Text] [Related]
34. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study.
Mazhar F; Akram S; Haider N; Hadi MA; Sultana J
Int J Clin Pharm; 2018 Jun; 40(3):700-703. PubMed ID: 29721741
[TBL] [Abstract][Full Text] [Related]
35. Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature.
Mason J; Pirmohamed M; Nunn T
Eur J Clin Pharmacol; 2012 Jan; 68(1):21-8. PubMed ID: 21779968
[TBL] [Abstract][Full Text] [Related]
36. Incidence of unlicensed and off-label prescription in children.
Langerová P; Vrtal J; Urbánek K
Ital J Pediatr; 2014 Feb; 40():12. PubMed ID: 24495454
[TBL] [Abstract][Full Text] [Related]
37. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine.
Khdour MR; Hallak HO; Alayasa KS; AlShahed QN; Hawwa AF; McElnay JC
Int J Clin Pharm; 2011 Aug; 33(4):650-5. PubMed ID: 21567279
[TBL] [Abstract][Full Text] [Related]
38. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
Ellul IC; Grech V; Attard-Montalto S
Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
[TBL] [Abstract][Full Text] [Related]
39. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.
Czarniak P; Bint L; Favié L; Parsons R; Hughes J; Sunderland B
PLoS One; 2015; 10(3):e0120630. PubMed ID: 25756896
[TBL] [Abstract][Full Text] [Related]
40. Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study.
Kieran EA; O'Callaghan N; O'Donnell CP
Acta Paediatr; 2014 Apr; 103(4):e139-42. PubMed ID: 24397831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
